ニューズレター：世界のがん治療薬情報

Monitoring business developments in world anticancer drug markets is becoming more and more vital as cancer, in all its guises, remains one of the most resistant conditions, and its position in the pharmaceutical industry is assured.

In an effort to stay in touch with the companies, products, alliances and research that are shaping the global cancer market, Espicom has launched this major new publication.

Cancer Drug News (CDN) can save you the time and effort of ensuring you have the necessary information to keep up-to-date with the developments in this world market. Incorporating primary resource material augmented with data from Espicom's unique intelligence base, CDN provides a compelling, easy-to-read route to complete market knowledge.

The following sections appear in every issue:

Therapies for Cancer-Related Complications
General Development News
Conference Listings

A selection of the following topics will appear each month, depending on news availability:

Breast Cancer
Haematological Cancers
Liver Cancer
Gastro-Intestinal Cancers
Lung Cancer
Gynaecological Cancers
Genito-Urinary Cancers
Brain Tumours
Head and Neck Cancers
Melanoma/Sarcoma